Literature DB >> 16681726

Gene expression patterns in advanced human cervical cancer.

P W Grigsby1, M Watson, M A Powell, Z Zhang, J S Rader.   

Abstract

The purpose of this study was to evaluate gene expression patterns in human cervical tumors by extent of lymph node metastases at diagnosis. Pretreatment whole-body fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging was performed in eight patients with invasive squamous cell carcinoma of the cervix to evaluate the extent of lymph nodes metastases. Pretreatment tumor tissue samples were subjected to laser-capture microdissection, and isolated RNA was linearly amplified and hybridized to Affymetrix Human U95A GeneChip microarrays. Molecular FDG-PET imaging revealed that three patients had lymph node involvement in the supraclavicular region and five patients did not. Microarray data were segregated into two groups based on the extent of regional lymph node involvement. Supervised clustering analysis identified 75 of about 12,000 gene transcripts represented on the array whose average expression was at least threefold different. We identified 12 of the 75 transcripts that demonstrated a statistically significant difference in expression between the two patient groups (P < 0.05). Five transcripts were upregulated and seven downregulated. Both overall and cause-specific survivals were different between these two patient groups (P= 0.006). This limited data set identified candidate biomarkers of extent of lymph node metastases that correlated with poor survival outcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16681726     DOI: 10.1111/j.1525-1438.2006.00389.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  13 in total

Review 1.  Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer.

Authors:  Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

2.  Decreased local immune response and retained HPV gene expression during chemoradiotherapy are associated with treatment resistance and death from cervical cancer.

Authors:  Pippa F Cosper; Christopher McNair; Iván González; Nathan Wong; Karen E Knudsen; Jason J Chen; Stephanie Markovina; Julie K Schwarz; Perry W Grigsby; Xiaowei Wang
Journal:  Int J Cancer       Date:  2019-12-04       Impact factor: 7.396

3.  Use of DNA microarray and small animal positron emission tomography in preclinical drug evaluation of RAF265, a novel B-Raf/VEGFR-2 inhibitor.

Authors:  Jeffrey R Tseng; Darrin Stuart; Kimberly Aardalen; Angelo Kaplan; Natasha Aziz; Nicholas P Hughes; Sanjiv S Gambhir
Journal:  Neoplasia       Date:  2011-03       Impact factor: 5.715

4.  Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancer.

Authors:  Fei Yang; Maria A Thomas; Farrokh Dehdashti; Perry W Grigsby
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-23       Impact factor: 9.236

5.  Gene expression profiles in HPV-immortalized human cervical cells treated with the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  Bogdan Prokopczyk; Indu Sinha; Neil Trushin; Willard M Freeman; Karam El-Bayoumy
Journal:  Chem Biol Interact       Date:  2008-11-06       Impact factor: 5.192

Review 6.  The prognostic value of PET and PET/CT in cervical cancer.

Authors:  Perry W Grigsby
Journal:  Cancer Imaging       Date:  2008-07-24       Impact factor: 3.909

7.  Quantitative gene expression assessment identifies appropriate cell line models for individual cervical cancer pathways.

Authors:  Mark W Carlson; Vishwanath R Iyer; Edward M Marcotte
Journal:  BMC Genomics       Date:  2007-05-10       Impact factor: 3.969

8.  Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer.

Authors:  Heidi Lyng; Runar S Brøvig; Debbie H Svendsrud; Ruth Holm; Olav Kaalhus; Kjetil Knutstad; Halldis Oksefjell; Kolbein Sundfør; Gunnar B Kristensen; Trond Stokke
Journal:  BMC Genomics       Date:  2006-10-20       Impact factor: 3.969

9.  Epithelial-mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy.

Authors:  Leonardo Rojas-Puentes; Andrés F Cardona; Hernán Carranza; Carlos Vargas; Luis F Jaramillo; Delma Zea; Lucely Cetina; Beatriz Wills; Erika Ruiz-Garcia; Oscar Arrieta
Journal:  Cancer Med       Date:  2016-05-27       Impact factor: 4.452

10.  Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.

Authors:  Chunliang Shang; Wenhui Zhu; Tianyu Liu; Wei Wang; Guangxin Huang; Jiaming Huang; Peizhen Zhao; Yunhe Zhao; Shuzhong Yao
Journal:  Oncol Rep       Date:  2016-03-29       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.